Currently, there are 23 coronavirus vaccines in the clinical trials around the world and another 140 in early-stage development, showing that the race to defeat the virus has started to take shape. One vaccine candidate, being developed by clinical research teams at Oxford University’s Jenner Institute and Oxford Vaccine Group in collaboration with AstraZeneca seems to have taken an early lead in the race towards the discovery of a safe, effective and accessible vaccine against the novel coronavirus. Here’s everything you need to know about the vaccine, known as ChAdOx1 nCoV-19.